Compare EW & MET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EW | MET |
|---|---|---|
| Founded | 1958 | 1863 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 65.4B |
| IPO Year | 1999 | 1999 |
| Metric | EW | MET |
|---|---|---|
| Price | $106.66 | $100.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 30 | 18 |
| Target Price | ★ $113.39 | $111.13 |
| AVG Volume (30 Days) | ★ 4.4M | 2.8M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.61 | ★ 6.48 |
| Revenue | $6,067,600,000.00 | ★ $77,084,000,000.00 |
| Revenue This Year | $12.23 | $3.08 |
| Revenue Next Year | $9.84 | $4.51 |
| P/E Ratio | $66.63 | ★ $15.79 |
| Revenue Growth | ★ 11.55 | 8.59 |
| 52 Week Low | $74.66 | $67.33 |
| 52 Week High | $107.69 | $106.72 |
| Indicator | EW | MET |
|---|---|---|
| Relative Strength Index (RSI) | 77.78 | 52.36 |
| Support Level | $82.21 | $92.95 |
| Resistance Level | N/A | $103.65 |
| Average True Range (ATR) | 3.38 | 2.38 |
| MACD | 1.06 | -0.03 |
| Stochastic Oscillator | 93.83 | 38.26 |
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.